Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
about
Cutaneous lymphomasSystemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell LymphomaExtracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Mycosis fungoides in Iranian population: an epidemiological and clinicopathological studyPhase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.New and established treatment options for mycosis fungoides and Sézary syndrome - an update.A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience.Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.Prognostic factors and risk stratification in early mycosis fungoides.Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome.Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases.Cutaneous lymphomas.Prognostic indicators for mycosis fungoides in a Greek population.Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides
P2860
Q27693872-A9890A63-A39D-4929-BA34-39757EDEBCA3Q30239965-234CB971-B291-4FF5-A047-D07C3C6E2652Q30276132-A0950721-0F0C-4B7B-8F60-5166DB972847Q30650570-722428C6-0A62-4A7E-AA16-955B4900B6E5Q35074418-3D33F4A2-E04A-4C6B-B2DC-86757F11ACA7Q35222112-0D72B24D-B0F2-4091-8A2F-382149D7D584Q37163606-2DC9B193-1710-4DE6-A0F3-7C152DF93CD8Q37689051-E90582F7-2CAC-424C-BAA7-C82DF4A67716Q38196931-80DEF484-87D5-4AB4-9377-24C646483192Q38212880-675F5491-8AE1-456A-8434-97F8E6FA8598Q38216976-05C43F7D-663F-42DA-A294-4676BD6BA24BQ39014399-36B11951-59A5-4302-911B-6A9E2BF1E163Q40398285-0FDD21E6-E5D3-48D9-BE22-9333CBA6FB25Q41342946-90D36596-F062-455B-BD8F-02FEF9B7CCDFQ43632085-3AEA688B-D18D-40AB-8C67-8E945E27DDE3Q43680684-33B50608-04A4-4384-BFF9-79F3045B88B8Q47818116-BA3EEAAC-E066-4F5C-A712-380093035F00Q47898250-9DA833ED-5030-48ED-A634-8DF558C6E3F3Q51104502-3625547C-D0EB-45D0-A61A-8641E9490F90Q51231548-F01B9CF0-E4CA-4E54-9FBD-AB10954386ACQ53039521-FAF35A24-E9AA-41BF-BEBB-4548C0D593D8Q57561035-01F7D366-A5B2-4B47-858E-0116B7E96551
P2860
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@en
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@nl
type
label
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@en
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@nl
prefLabel
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@en
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@nl
P2093
P2860
P50
P356
P1433
P1476
Time course, clinical pathways ...... Group of Cutaneous Lymphomas.
@en
P2093
Angela Maria Mamusa
Angelo Carbone
Giuseppe Alfonso Lombardo
Gruppo Italiano Linfomi Cutanei
Maria Grazia Bernengo
Mauro Alaibac
Michele Fimiani
Nicola Pimpinelli
Paolo Fava
Pietro Quaglino
P2860
P304
P356
10.1002/CNCR.27627
P407
P577
2012-06-06T00:00:00Z